Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic closed-angle glaucoma].

F Valtot1

  • 1Institut du Glaucome, Fondation Hôpital Saint-Joseph, 185 rue Raymond Losserand, 75674 Paris Cedex 14.

Journal Francais D'Ophtalmologie
|August 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[New diagnosis approaches: our experience with Octopus Field Analysis (OFA V2.2), the new software for analysis of visual field].

Journal francais d'ophtalmologie·2009
Same author

[Glaucoma and age-related macular degeneration intricacy].

Journal francais d'ophtalmologie·2008
Same author

[What should be done when laser iridotomy does not physically eliminate angle closure?].

Journal francais d'ophtalmologie·2006
Same author

[Practical assessment. Clinical evaluation of normal-tension glaucoma].

Journal francais d'ophtalmologie·2005
Same author

Nonpenetrating deep sclerectomy: a 6-year retrospective study.

European journal of ophthalmology·2004
Same author

[The refractory glaucomas].

Journal francais d'ophtalmologie·2003
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
Same journal

Sequential dexamethasone and fluocinolone acetonide intravitreal implants to treat macular edema in non-infectious uveitis.

Journal francais d'ophtalmologie·2026
Same journal

Intravitreal anti-VEGF therapy: Comparative evaluation of appropriateness and readability of large language model chatbots' responses to frequently asked patient questions.

Journal francais d'ophtalmologie·2026
Same journal

[Trabecular surgeries in the management of glaucoma: A review of literature].

Journal francais d'ophtalmologie·2026
Same journal

Cataract surgery in eyes with nanophthalmos: Operative technique and refractive outcomes - A case series.

Journal francais d'ophtalmologie·2026
See all related articles

Chronic closed-angle glaucoma is often missed, leading to severe vision loss. Early diagnosis with gonioscopy and ultrasound biomicroscopy, followed by iridotomy, is crucial for managing this condition.

Area of Science:

  • Ophthalmology
  • Glaucoma Research

Background:

  • Chronic closed-angle glaucoma (CCG) is significantly more prevalent than the acute form.
  • CCG frequently remains undiagnosed for extended periods, leading to substantial visual field deficits and potential eye loss.

Purpose of the Study:

  • To highlight the diagnostic challenges of chronic closed-angle glaucoma.
  • To emphasize the importance of specific diagnostic tools and treatment for CCG.

Main Methods:

  • Diagnosis relies on gonioscopy to identify characteristic features.
  • Ultrasound biomicroscopy (UBM) is employed when gonioscopy results are inconclusive, detecting conditions like goniosynechiae, ciliary body/lens malposition, or iridociliary cysts.

Main Results:

  • Pupillary block is the initiating factor in most CCG cases (approximately 90%).

Related Experiment Videos

  • Iridotomy is the recommended intervention for pupillary block, though it may not be a complete solution on its own.
  • Conclusions:

    • Accurate diagnosis of CCG requires specialized techniques like gonioscopy and UBM.
    • Prompt intervention, including iridotomy, is essential for managing CCG and preventing irreversible vision damage.